Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates Entered into ...

Eli Lilly will raise UK list prices for its Mounjaro weight-loss jab by as much as 170% from September after Donald Trump ...

When ideology overtakes pragmatism in crafting public policies, it portends danger to society. The recent decision by the ...

Make like a mattress company and sell shots and pills straight to the consumer.It’s a strategy that companies such as Hims & Hers Health and Ro have pursued for years, mostly to sell inexpensive, ...